Insider Selling: Trulieve Cannabis (NYSE:TRLV) CEO Sells $1,198,464.36 in Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 136,811 shares of the stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $8.76, for a total value of $1,198,464.36. Following the completion of the transaction, the chief executive officer owned 1,476,913 shares in the company, valued at approximately $12,937,757.88. The trade was a 8.48% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Stock Performance

Shares of NYSE TRLV opened at $8.93 on Monday. Trulieve Cannabis Corp. has a fifty-two week low of $3.50 and a fifty-two week high of $13.28.

Analysts Set New Price Targets

TRLV has been the subject of several recent analyst reports. Weiss Ratings started coverage on shares of Trulieve Cannabis in a research report on Tuesday, June 16th. They set a “sell (d-)” rating for the company. Zacks Research raised shares of Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Reduce”.

About Trulieve Cannabis

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.